These gene mutations alter key signaling pathways in liver cancer cells, e.g., telomere maintenance, Wnt/β-catenin, P53/cell cycle regulation, Akt/mTOR, MAP kinase and oxidative stress (ref. [7, 34, 35]). Here, TP53 is linked to liver cancer.